XML 17 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' EQUITY (DEFICIT) (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Balance at Dec. 31, 2020 $ 158,103 $ 2 $ 249,175 $ 2 $ (91,076)
Balance, shares at Dec. 31, 2020   23,384,969      
Stock-based compensation 1,577   1,577    
Exercise of stock options 249   249    
Exercise of stock options, shares   88,734      
Comprehensive loss:          
Unrealized loss on investments 10     10  
Net loss (11,050)       (11,050)
Balance at Mar. 31, 2021 148,889 $ 2 251,001 12 (102,126)
Balance, shares at Mar. 31, 2021   23,473,703      
Balance at Dec. 31, 2020 158,103 $ 2 249,175 2 (91,076)
Balance, shares at Dec. 31, 2020   23,384,969      
Comprehensive loss:          
Net loss (23,590)        
Balance at Jun. 30, 2021 138,274 $ 2 252,920 18 (114,666)
Balance, shares at Jun. 30, 2021   23,570,593      
Balance at Dec. 31, 2020 158,103 $ 2 249,175 2 (91,076)
Balance, shares at Dec. 31, 2020   23,384,969      
Comprehensive loss:          
Net loss (56,600)        
Balance at Dec. 31, 2021 109,268 $ 2 256,948 18 (147,700)
Balance, shares at Dec. 31, 2021   23,668,747      
Balance at Mar. 31, 2021 148,889 $ 2 251,001 12 (102,126)
Balance, shares at Mar. 31, 2021   23,473,703      
Stock-based compensation 1,813   1,813    
Exercise of stock options 106   106    
Exercise of stock options, shares   96,890      
Comprehensive loss:          
Unrealized loss on investments 6     6  
Net loss (12,540)       (12,540)
Balance at Jun. 30, 2021 138,274 $ 2 252,920 18 (114,666)
Balance, shares at Jun. 30, 2021   23,570,593      
Balance at Dec. 31, 2021 109,268 $ 2 256,948 18 (147,700)
Balance, shares at Dec. 31, 2021   23,668,747      
Stock-based compensation 1,752   1,752    
Exercise of stock options 240   240    
Exercise of stock options, shares   149,664      
Comprehensive loss:          
Unrealized loss on investments (132)     (132)  
Foreign currency translation adjustment (15)     (15)  
Net loss (16,884)       (16,884)
Balance at Mar. 31, 2022 94,229 $ 2 258,940 (129) (164,584)
Balance, shares at Mar. 31, 2022   23,818,411      
Balance at Dec. 31, 2021 $ 109,268 $ 2 256,948 18 (147,700)
Balance, shares at Dec. 31, 2021   23,668,747      
Exercise of stock options, shares 151,342        
Comprehensive loss:          
Net loss $ (32,145)        
Balance at Jun. 30, 2022 149,176 $ 4 329,414 (397) (179,845)
Balance, shares at Jun. 30, 2022   40,097,076      
Balance at Mar. 31, 2022 94,229 $ 2 258,940 (129) (164,584)
Balance, shares at Mar. 31, 2022   23,818,411      
Stock-based compensation 2,185   2,185    
Issuance of common stock, net of issuance costs 56,137 $ 2 56,135    
Issuance of common stock, net of issuance costs, shares   16,276,987      
Issuance of pre-funded warrants, net of issuance costs 12,150   12,150    
Exercise of stock options 4   4    
Exercise of stock options, shares   1,678      
Comprehensive loss:          
Unrealized loss on investments (225)     (225)  
Foreign currency translation adjustment (43)     (43)  
Net loss (15,261)       (15,261)
Balance at Jun. 30, 2022 $ 149,176 $ 4 $ 329,414 $ (397) $ (179,845)
Balance, shares at Jun. 30, 2022   40,097,076